Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
285
datasets available to search
ShareScore release 0.9.0
Dataset results
285 results for “regorafenib”
[18F]FLT-PET as a Predictive Imaging Biomaker of Treatment Responses to Regorafenib
ClinicalTrials.gov study NCT02175095. IPD Sharing: Not stated. Countries: 1. Publications: 27.
Phase I/II Study of SGI-110 With Irinotecan Versus Regorafenib or TAS-102 in Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT01896856. IPD Sharing: NO. Countries: 2. Publications: 2.
A Study of Nivolumab Combined With FOLFOX and Regorafenib in People Who Have HER2-Negative Esophagogastric Cancer
ClinicalTrials.gov study NCT04757363. IPD Sharing: YES. Countries: 1. Publications: 1.
A Biomarker Study in Patients Getting Regorafenib for Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT02402036. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Regorafenib in Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT02466009. IPD Sharing: Not stated. Countries: 1. Publications: 1.
(VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST
ClinicalTrials.gov study NCT03465722. IPD Sharing: Not stated. Countries: 18. Publications: 3.
Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT02368886. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study on the Effectiveness and Safety of the Combination of the Two Drugs Regorafenib and Nivolumab in Patients With Colorectal Cancer (Cancer of the Colon or Rectum Classified as Proficient Mismatch
ClinicalTrials.gov study NCT04126733. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Safety, Tolerability and Efficacy of Regorafenib in Combination With FOLFIRINOX in Patients With Colorectal Cancer
ClinicalTrials.gov study NCT03828799. IPD Sharing: YES. Countries: 1. Publications: 22.
Study of Regorafenib as a 3rd-line or Beyond Treatment for Gastrointestinal Stromal Tumors (GIST)
ClinicalTrials.gov study NCT01271712. IPD Sharing: Not stated. Countries: 17. Publications: 4.
A Study to Investigate Efficacy and Safety of Cobimetinib Plus Atezolizumab and Atezolizumab Monotherapy Versus Regorafenib in Participants With Metastatic Colorectal Adenocarcinoma (COTEZO IMblaze370
ClinicalTrials.gov study NCT02788279. IPD Sharing: Not stated. Countries: 11. Publications: 3.
Phase Ib Study of SUnitinib Alternating With REgorafenib in Patients With Metastatic and/or Unresectable GIST
ClinicalTrials.gov study NCT02164240. IPD Sharing: Not stated. Countries: 1. Publications: 1.
SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes
ClinicalTrials.gov study NCT02048371. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT01298570. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Regorafenib and Nivolumab Simultaneous Combination Therapy
ClinicalTrials.gov study NCT03406871. IPD Sharing: NO. Countries: 1. Publications: 1.
Vorinostat Plus Hydroxychloroquine Versus Regorafenib in Colorectal Cancer
ClinicalTrials.gov study NCT02316340. IPD Sharing: Not stated. Countries: 1. Publications: 1.
First Line Treatment of Metastatic Colorectal Cancer With mFOLFOX6 in Combination With Regorafenib
ClinicalTrials.gov study NCT01289821. IPD Sharing: Not stated. Countries: 7. Publications: 1.
A Study Using Regorafenib as Second or Third Line Therapy in Metastatic Medullary Thyroid Cancer
ClinicalTrials.gov study NCT02657551. IPD Sharing: NO. Countries: 1. Publications: 1.
To Determine the Safety of Regorafenib, Hydroxychloroquine, and Entinostat Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT03215264. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase 2 Randomized, Open-Label Study of RRx-001 vs Regorafenib in Subjects With Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT02096354. IPD Sharing: Not stated. Countries: 1. Publications: 4.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.